HEALTH

Type 2 diabetes linked with cognitive impairments, study shows

BY Allison Cerra

WASHINGTON A small study conducted by Canadian researchers found factors that may link Type 2 diabetes with such cognitive impairments as dementia.

Older adults with diabetes who also have high blood pressure, walk slowly or lose their balance, or believe they’re in bad health, are more likely to have poorer cognitive functions than those without these problems, according to a new study conducted by researchers at the University of Alberta in Canada and published in the September issue of Neuropsychology

The study of older Canadians — 41 adults with Type 2 diabetes, ages 55 to 81 years, and 458 matched healthy controls (ages 53 to 90 years) — found that systolic blood pressure, a low combination score for gait and balance, and a patient’s own reports of poor health all played a statistically significant role in the relationship between diabetes and cognitive impairment.

“Awareness of the link between diabetes and cognition could help people realize how important it is to manage this disease, and to motivate them to do so,” said co-author Roger Dixon, PhD, of the University of Alberta.

Type 2 diabetes has been found by other researchers to nearly double the risk of dementia and Alzheimer’s disease, said Dixon, who studies how health affects cognition in aging. As diabetes becomes more common, this heightened risk could dramatically hike the number of older people with dementia.

The prevalence of diabetes in the United States for people older than age 60 — according to the National Institute of Diabetes and Digestive and Kidney Diseases — is more than 23%, while Canadian prevalence is nearly 19%, according to the Public Health Agency of Canada.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Abbott acquires Piramal’s Healthcare Solutions business

BY Alaric DeArment

ABBOTT PARK, Ill. Abbott has gained a foothold in the Indian drug market through its acquisition of the Healthcare Solutions business from Piramal, Abbott said.

 

Abbott announced Wednesday that it had completed its acquisition of the business, saying it would further accelerate its growth in emerging markets, which currently account for more than 20% of its sales. The company expects its pharmaceutical sales in India to be more than $2.5 billion by 2020.

 

 

“The acquisition of Piramal’s Healthcare Solutions business further strengthens Abbott’s growing presence in emerging markets,” Abbott chairman and CEO Miles White said. “Piramal’s portfolio of well-known, trusted products has served patients in India for decades.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

N.C. law enforcement seeks access to pharmacy records to curb Rx abuse

BY Alaric DeArment

RALEIGH, N.C. Residents in North Carolina prescribed controlled substances could receive some attention from more than their physicians and pharmacists, according to published reports.

 

The Raleigh, N.C., News & Observer reported Wednesday that the state sheriff’s association wants law enforcement to have access to computer records of patients prescribed such controlled substances as Purdue Pharma’s OxyContin (oxycodone) and Sanofi-Aventis’ Ambien (zolpidem tartrate). The association argued in favor of the idea Tuesday before a healthcare committee of the state legislature.

 

 

The sheriffs said gaining access to the records would enable them to combat abuse of prescription drugs. Groups, such as the American Civil Liberties Union, have opposed such efforts in the past, citing concerns over patient privacy.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES